Search Results

Immunosuppression and atypical infections in CML patients treated with dasatinib at 140 mg daily

Authors: Sillaber, C.; Herrmann, H.; Bennett, K.; Rix, U.; Baumgartner, C.; Böhm, A.; Herndlhofer, S.; Tschachler, E.; Superti-Furga, G.; Jäger, U.; Valent, P.

Source: European Journal of Clinical Investigation, Volume 39, Number 12, December 2009 , pp. 1098-1109(12)

Publisher: Blackwell Publishing

Azacitidine: A Review of its Use in Higher-Risk Myelodysplastic Syndromes/Acute Myeloid Leukaemia

Author: Keating, Gillian M.

Source: Drugs, Volume 69, Number 17, 3 December 2009 , pp. 2501-2518(18)

Publisher: Adis International

Peripheral neuropathy on imatinib treatment for chronic myeloid leukaemia: suspected adverse drug interaction with amlodipine

Source: Internal Medicine Journal, Volume 39, Number 10, October 2009 , pp. 708-708(1)

Publisher: Blackwell Publishing

Interaction of nilotinib, dasatinib and bosutinib with ABCB1 and ABCG2: implications for altered anti-cancer effects and pharmacological properties

Authors: Hegedűs, C; Özvegy-Laczka, C; Apáti, Á; Magócsi, M; Német, K; Őrfi, L; Kéri, G; Katona, M; Takáts, Z; Váradi, A; Szakács, G; Sarkadi, B

Source: British Journal of Pharmacology, Volume 158, Number 4, October 2009 , pp. 1153-1164(12)

Publisher: Blackwell Publishing

in vitro Anti-leukaemia Activity of Pyrrolo[1,2-b][1,2,5]benzothiadiazepines (PBTDs)

Authors: Marfe, Gabriella; Stefano, Carla D.

Source: Recent Patents on Anti-Cancer Drug Discovery, Volume 5, Number 1, January 2010 , pp. 58-68(11)

Publisher: Bentham Science Publishers

Associated cancers in parents and offspring of polycythaemia vera and myelofibrosis patients

Authors: Hemminki, Kari; Sundquist, Jan; Bermejo, Justo L.

Source: British Journal of Haematology, Volume 147, Number 4, November 2009 , pp. 526-530(5)

Publisher: Blackwell Publishing

A Benefit-Risk Assessment of Imatinib in Chronic Myeloid Leukaemia and Gastrointestinal Stromal Tumours

Authors: Wolf, Dominik; Rumpold, Holger

Source: Drug Safety, Volume 32, Number 11, 1 November 2009 , pp. 1001-1015(15)

Publisher: Adis International

Metabolic characteristics of imatinib resistance in chronic myeloid leukaemia cells

Authors: Klawitter, Jelena; Kominsky, Douglas J; Brown, Jaimi L; Klawitter, Jost; Christians, Uwe; Leibfritz, Dieter; Melo, Junia V; Eckhardt, S Gail; Serkova, Natalie J

Source: British Journal of Pharmacology, Volume 158, Number 2, September 2009 , pp. 588-600(13)

Publisher: Blackwell Publishing

RQ-PCR based WT1 expression in comparison to BCR-ABL quantification can predict Philadelphia negative clonal evolution in patients with imatinib-treated chronic myeloid leukaemia

Authors: Schnittger, Susanne; Bacher, Ulrike; Kern, Wolfgang; Tschulik, Claudia; Weiss, Tamara; Haferlach, Claudia; Haferlach, Torsten

Source: British Journal of Haematology, Volume 146, Number 6, September 2009 , pp. 665-668(4)

Publisher: Blackwell Publishing

Effects of Imatinib Mesylate on Renin-Angiotensin System (RAS) Activity During the Clinical Course of Chronic Myeloid Leukaemia

Authors: Sayitoglu, M.; Haznedaroğlu, I.C.; Hatirnaz, O.; Erbilgin, Y.; Aksu, S.; Koca, E.; Adiguzel, C.; Bayik, M.; Akalin, I.; Gülbas, Z.; Akay, M.; Unal, A.; Kaynar, L.; Ovali, E.; Yilmaz, M.; Yenerel, M.; Dagdas, S.; Ozet, G.; Ar, C.; Aydin, Y.; Soysal, T.; Durgun, B.; Ozcebe, O.; Tukun, A.; Ilhan, O.; Ozbek, U.

Source: The Journal of International Medical Research, Volume 37, Number 4, July 2009 , pp. 1018-1028(11)

Publisher: Field House Publishing

The role of tyrosine kinase inhibitors in tuberous sclerosis

Authors: Koluman, Başak; Yegin, Zeynep Arzu; Yağcı, Münci

Source: British Journal of Haematology, Volume 147, Number 1, October 2009 , pp. 152-153(2)

Publisher: Blackwell Publishing

Abnormal centrosome-centriole cycle in chronic myeloid leukaemia?

Authors: Patel, Hetal; Gordon, Myrtle Y.

Source: British Journal of Haematology, Volume 146, Number 4, August 2009 , pp. 408-417(10)

Publisher: Blackwell Publishing

Isolated extraocular muscle involvement as the ophthalmic manifestation of leukaemia

Authors: Kiratli, Hayyam; Balci, Kadriye E; Himmetoğlu, Çiğdem; Üner, Ayşegül

Source: Clinical & Experimental Ophthalmology, Volume 37, Number 6, August 2009 , pp. 609-613(5)

Publisher: Blackwell Publishing

Clinical pathological and epidemiological assessment of morphologically and immunologically confirmed canine leukaemia

Authors: Adam, F.; Villiers, E.; Watson, S.; Coyne, K.; Blackwood, L.

Source: Veterinary and Comparative Oncology, Volume 7, Number 3, September 2009 , pp. 181-195(15)

Publisher: Blackwell Publishing

Dasatinib [Sprycel] is to be funded in New Zealand

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 584, 2009-08-08 , pp. 10-10(1)

Publisher: Adis International

Dasatinib-induced response in a rare case of chronic lymphocytic leukaemia associated with chronic myeloid leukaemia

Authors: Tecchio, Cristina; Nichele, Ilaria; Todeschini, Giuseppe; Pizzolo, Giovanni; Ambrosetti, Achille

Source: British Journal of Haematology, Volume 146, Number 2, July 2009 , pp. 222-223(2)

Publisher: Blackwell Publishing

Imatinib-induced pseudoporphyria

Authors: Timmer-de Mik, L.; Kardaun, S. H.; Kramer, M. H. H.; Hayes, D. P.; Bousema, M. T.

Source: Clinical & Experimental Dermatology, Volume 34, Number 6, August 2009 , pp. 705-707(3)

Publisher: Blackwell Publishing

Identification of a novel epitope derived from CML66 that is recognized by anti-leukaemia cytotoxic T lymphocytes

Authors: Suemori, Koichiro; Fujiwara, Hiroshi; Ochi, Toshiki; Azuma, Taichi; Yamanouchi, Jun; Narumi, Hiroshi; Yakushijin, Yoshihiro; Hato, Takaaki; Yasukawa, Masaki

Source: British Journal of Haematology, Volume 146, Number 1, July 2009 , pp. 115-118(4)

Publisher: Blackwell Publishing

Fluorouracil/nedaplatin: Fatal secondary acute and chronic myeloid leukaemias (first report with nedaplatin) and Burkitt leukaemia (first report): 4 case reports

Source: Reactions, Volume 1, Number 1257, 2009-06-20 , pp. 21-21(1)

Publisher: Adis International

Imatinib: a designer drug, another cutaneous complication

Authors: Dickens, E.; Lewis, F.; Bienz, N.

Source: Clinical & Experimental Dermatology, Volume 34, Number 5, July 2009 , pp. 603-604(2)

Publisher: Blackwell Publishing